Search
Modafinil
go.drugbank.com/drugs/DB00745ApprovedInvestigationalModafinil is a stimulant drug marketed as a 'wakefulness promoting agent' and is one of the stimulants used in the treatment of narcolepsy. … Narcolepsy is caused by dysfunction of a family of wakefulness-promoting and sleep-suppressing peptides, the orexins, whose neurons are activated by modafinil.
Categories: Cytochrome P-450 CYP1A2 Inducers, Cytochrome P-450 SubstratesSynonyms: 2-((diphenylmethyl)sulfinyl)acetamideSulfamethazine
go.drugbank.com/drugs/DB01582ApprovedVet approvedWithdrawnA sulfanilamide anti-infective agent. It has a spectrum of antimicrobial action similar to other sulfonamides.
Mixtures: Tylan 40 Sulfa-G Premix, KHC TRIMETHOMIX 400/80MG/G PREMIX POWDERSynonyms: N(1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide, N(1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamideLinperlisib
go.drugbank.com/drugs/DB17235InvestigationalSynonyms: N-(5-(6-fluoro-8-((4-(2-hydroxypropan-2-yl) piperidin-1-yl)methyl)-2-morpholinoquinazolin-4-yl)-2-methoxypyridin-3-)methanesulfonamide, N-[5-(6-fluoro-8-{[4-(2-hydroxypropan-2-yl) piperidin-1-yl]methyl}-2-morpholinoquinazolin-4-yl)-2-methoxypyridin-3-]methanesulfonamideLevobupivacaine
go.drugbank.com/drugs/DB01002ApprovedInvestigationalWithdrawnLevobupivacaine is an amino-amide local anaesthetic drug belonging to the family of n-alkylsubstituted pipecoloxylidide. It is the S-enantiomer of bupivacaine. … In particular, the specific levobupivacaine enantiomer is a worthwhile pursuit because it demonstrates less vasodilation and possesses a greater length of action in comparison to bupivacaine.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesSynonyms: L-(-)-1-Butyl-2',6'-pipecoloxylidide, (S)-1-butyl-2',6'-pipecoloxylidide2-deoxy-2-fluoro-β-D-galactose
go.drugbank.com/drugs/DB02228ExperimentalSynonyms: 2-deoxy-2-fluoro-β-D-galactose, 2-deoxy-2-fluoro-beta-D-galactose2-deoxy-2-fluoro-α-D-glucose
go.drugbank.com/drugs/DB04282ExperimentalSynonyms: 2-deoxy-2-fluoro-α-D-glucose, 2-deoxy-2-fluoro-alpha-D-glucose4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine
go.drugbank.com/drugs/DB08786ExperimentalSynonyms: 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE
go.drugbank.com/drugs/DB06918ExperimentalSynonyms: 2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE2-Deoxy-2-Amino Glucitol-6-Phosphate
go.drugbank.com/drugs/DB02445ExperimentalSynonyms: 2-Deoxy-2-Amino Glucitol-6-PhosphateSaxagliptin
go.drugbank.com/drugs/DB06335ApprovedInvestigationalSaxagliptin (rINN) is an orally active hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. FDA approved on July 31, 2009.
Synonyms: (1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrileMixtures: KOMBIGLYZE ® XR 5 MG/ 1000 MG, QTERN 5 MG/10 MG FİLM KAPLI TABLET, 28 ADET